Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gao, Z.
Right arrow Articles by Wolf, B. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gao, Z.
Right arrow Articles by Wolf, B. A.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes, Vol 45, Issue 7 854-862, Copyright © 1996 by American Diabetes Association


ARTICLES

Wortmannin inhibits insulin secretion in pancreatic islets and beta-TC3 cells independent of its inhibition of phosphatidylinositol 3-kinase

Z Gao, RJ Konrad, H Collins, FM Matschinsky, PL Rothenberg and BA Wolf
Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, USA.

Glucose is the primary stimulus for insulin secretion by pancreatic beta-cells, and it triggers membrane depolarization and influx of extracellular Ca2+. Cholinergic agonists amplify insulin release by several pathways, including activation of phospholipase C, which hydrolyzes membrane polyphosphoinositides. A novel phospholipid, phosphatidylinositol 3,4,5- trisphosphate [PtdIns(3,4,5)P3], a product of phosphatidylinositol 3-kinase (PI 3-kinase), has recently been found in various cell types. We demonstrate by immunoblotting that PI 3-kinase is present in both cytosolic and membrane fractions of insulin-secreting beta-TC3 cells and in rat islets. The catalytic activity of PI 3-kinase in immunoprecipitates of islets and beta-TC3 cells was measured by the production of radioactive phosphatidylinositol 3-monophosphate from phosphatidylinositol (PtdIns) in the presence of [gamma-32P]ATP. Wortmannin, a fungal metabolite, dose dependently inhibited PI 3-kinase activity of both islets and beta-TC3 cells, with an IC50 of 1 nmol/l and a maximally effective concentration of 100 nmol/l, when it was added directly to the kinase assay. However, if intact islets were incubated with wortmannin and PI 3-kinase subsequently was determined in islet immunoprecipitates, approximately 50% inhibition of PI 3-kinase activity (but no inhibition of glucose- and carbachol-stimulated insulin secretion) from intact islets was obtained at wortmannin concentrations of 100 nmol/l. Wortmannin, at higher concentrations (1 and 10 micromol/l), inhibited glucose- and carbachol-induced insulin secretion of Intact rat islets by 58 and 92%, respectively. Wortmannin had no effect on the basal insulin release from rat islets. A similar dose curve of inhibition of glucose- and carbachol-induced insulin secretion by wortmannin was obtained when beta-TC3 cells were used. Cellular metabolism was, not changed by any wortmannin concentrations tested (0.01-10 micromol/l). Both basal cytosolic [Ca2+]i and carbamyl choline-induced increases of [Ca2]i were unaffected by wortmannin in the presence of 2.5 mmol/l Ca2+, while Ca2+ mobilization from intracellular stores was partially decreased by wortmannin. Together, these data suggest that wortmannin at concentrations that inhibit PI 3-kinase does not affect insulin secretion. PI 3-kinase is unlikely to have a major role in insulin secretion induced by glucose and carbachol.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
DiabetesHome page
A. I. Tarasov, C. A.J. Girard, and F. M. Ashcroft
ATP Sensitivity of the ATP-Sensitive K+ Channel in Intact and Permeabilized Pancreatic {beta}-Cells
Diabetes, September 1, 2006; 55(9): 2446 - 2454.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
J. Yang, R. K. Wong, M. Park, J. Wu, J. R. Cook, D. A. York, S. Deng, J. Markmann, A. Naji, B. A. Wolf, et al.
Leucine Regulation of Glucokinase and ATP Synthase Sensitizes Glucose-Induced Insulin Secretion in Pancreatic {beta}-Cells
Diabetes, January 1, 2006; 55(1): 193 - 201.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
C. Broca, V. Breil, C. Cruciani-Guglielmacci, M. Manteghetti, C. Rouault, M. Derouet, S. Rizkalla, B. Pau, P. Petit, G. Ribes, et al.
Insulinotropic agent ID-1101 (4-hydroxyisoleucine) activates insulin signaling in rat
Am J Physiol Endocrinol Metab, September 1, 2004; 287(3): E463 - E471.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
R. N. Kulkarni, M. G. Roper, G. Dahlgren, D. Q. Shih, L. M. Kauri, J. L. Peters, M. Stoffel, and R. T. Kennedy
Islet Secretory Defect in Insulin Receptor Substrate 1 Null Mice Is Linked With Reduced Calcium Signaling and Expression of Sarco(endo)plasmic Reticulum Ca2+-ATPase (SERCA)-2b and -3
Diabetes, June 1, 2004; 53(6): 1517 - 1525.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
S. Srivastava and H. J. Goren
Insulin Constitutively Secreted by {beta}-Cells Is Necessary for Glucose-Stimulated Insulin Secretion
Diabetes, August 1, 2003; 52(8): 2049 - 2056.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
J.-W. Lee, A. G. Swick, and D. R. Romsos
Leptin Constrains Phospholipase C-Protein Kinase C-Induced Insulin Secretion via a Phosphatidylinositol 3-Kinase-Dependent Pathway
Experimental Biology and Medicine, February 1, 2003; 228(2): 175 - 182.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. Chen, Z. Yang, R. Wu, and J. L. Nadler
Lisofylline, a Novel Antiinflammatory Agent, Protects Pancreatic {beta}-Cells from Proinflammatory Cytokine Damage by Promoting Mitochondrial Metabolism
Endocrinology, June 1, 2002; 143(6): 2341 - 2348.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
J. Westerlund, B. A. Wolf, and P. Bergsten
Glucose-Dependent Promotion of Insulin Release From Mouse Pancreatic Islets by the Insulin-Mimetic Compound L-783,281
Diabetes, February 1, 2002; 51(90001): S50 - 52.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
K. Eto, T. Yamashita, Y. Tsubamoto, Y. Terauchi, K. Hirose, N. Kubota, S. Yamashita, J. Taka, S. Satoh, H. Sekihara, et al.
Phosphatidylinositol 3-Kinase Suppresses Glucose-Stimulated Insulin Secretion by Affecting Post-Cytosolic [Ca2+] Elevation Signals
Diabetes, January 1, 2002; 51(1): 87 - 97.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
G. Xu, G. Kwon, W. S. Cruz, C. A. Marshall, and M. L. McDaniel
Metabolic Regulation by Leucine of Translation Initiation Through the mTOR-Signaling Pathway by Pancreatic {beta}-Cells
Diabetes, February 1, 2001; 50(2): 353 - 360.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
W. S. Zawalich and K. C. Zawalich
A Link between Insulin Resistance and Hyperinsulinemia: Inhibitors of Phosphatidylinositol 3-Kinase Augment Glucose-Induced Insulin Secretion from Islets of Lean, But Not Obese, Rats
Endocrinology, September 1, 2000; 141(9): 3287 - 3295.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. D. Turner and P. Arvan
Protein Traffic from the Secretory Pathway to the Endosomal System in Pancreatic beta -Cells
J. Biol. Chem., May 5, 2000; 275(19): 14025 - 14030.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. G. Xu, Z.-y. Gao, P. D. Borge Jr., and B. A. Wolf
Insulin Receptor Substrate 1-induced Inhibition of Endoplasmic Reticulum Ca2+ Uptake in beta -Cells. AUTOCRINE REGULATION OF INTRACELLULAR Ca2+ HOMEOSTASIS AND INSULIN SECRETION
J. Biol. Chem., June 18, 1999; 274(25): 18067 - 18074.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
A. Ptasznik, G. M. Beattie, M. I. Mally, V. Cirulli, A. Lopez, and A. Hayek
Phosphatidylinositol 3-Kinase Is a Negative Regulator of Cellular Differentiation
J. Cell Biol., June 2, 1997; 137(5): 1127 - 1136.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Z. Gao, J. Reavey-Cantwell, R. A. Young, P. Jegier, and B. A. Wolf
Synaptotagmin III/VII Isoforms Mediate Ca2+-induced Insulin Secretion in Pancreatic Islet beta -Cells
J. Biol. Chem., November 10, 2000; 275(46): 36079 - 36085.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J.-P. Gratton, M. Morales-Ruiz, Y. Kureishi, D. Fulton, K. Walsh, and W. C. Sessa
Akt Down-regulation of p38 Signaling Provides a Novel Mechanism of Vascular Endothelial Growth Factor-mediated Cytoprotection in Endothelial Cells
J. Biol. Chem., August 3, 2001; 276(32): 30359 - 30365.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. A. Aspinwall, W.-J. Qian, M. G. Roper, R. N. Kulkarni, C. R. Kahn, and R. T. Kennedy
Roles of Insulin Receptor Substrate-1, Phosphatidylinositol 3-Kinase, and Release of Intracellular Ca2+ Stores in Insulin-stimulated Insulin Secretion in beta -Cells
J. Biol. Chem., July 14, 2000; 275(29): 22331 - 22338.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 1996 by the American Diabetes Association.